Pan - Ebola
Alternative Names: Pan-Ebola/Sudan; Pan-Ebola/Sudan - Emergent biosciences; Pan-Sudan; Pan-Sudan/ EbolaLatest Information Update: 20 Sep 2023
Price :
$50 *
At a glance
- Originator Emergent BioSolutions
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Ebola virus infections
Most Recent Events
- 15 Jun 2023 Preclinical trials in Ebola virus infections in USA (Parenteral) (Emergent BioSolutions pipeline, June 2023)